CDSCO Steps Up Controls on Clinical Trials in India With 14 New Regs

International Pharmaceutical Regulatory Monitor
A A
Clinical trial investigators in India must limit their work to no more than three trials at any given time, according to one of the mandates in 14 finalized regulations issued by the Central Drugs Standard Control Organization.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00